These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21919387)

  • 1. [The pharmacokinetic process: is the drug getting to its site of action?: Drug metabolism].
    Carrillo Norte JA
    Rev Enferm; 2011; 34(7-8):52-60. PubMed ID: 21919387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolism of drugs. I. Basic metabolic reactions].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):446-52. PubMed ID: 16161932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of drug metabolism--implications for drug interaction].
    Sitkiewicz D
    Pol Merkur Lekarski; 2000 Sep; 9(51):595-7. PubMed ID: 11126981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochromes P450: decision-making tools for personalized therapeutics.
    Murray M; Petrovic N
    Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug control of steroid metabolism by the hepatic endoplasmic reticulum.
    Feuer G
    Drug Metab Rev; 1983; 14(6):1119-44. PubMed ID: 6373207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cytochrome P450-mediated bioactivation and its toxicological relevance.
    Gan J; Ma S; Zhang D
    Drug Metab Rev; 2016 Nov; 48(4):473-501. PubMed ID: 27533622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of drug metabolism and interactions on the basis of in vitro investigations.
    Pelkonen O; Turpeinen M; Uusitalo J; Rautio A; Raunio H
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):167-75. PubMed ID: 15733211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae.
    Alderton W; Berghmans S; Butler P; Chassaing H; Fleming A; Golder Z; Richards F; Gardner I
    Xenobiotica; 2010 Aug; 40(8):547-57. PubMed ID: 20528625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated induction of drug transporters and phase I and II metabolism in human liver slices.
    Olinga P; Elferink MG; Draaisma AL; Merema MT; Castell JV; Pérez G; Groothuis GM
    Eur J Pharm Sci; 2008 Apr; 33(4-5):380-9. PubMed ID: 18328680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations.
    van de Kerkhof EG; Ungell AL; Sjöberg AK; de Jager MH; Hilgendorf C; de Graaf IA; Groothuis GM
    Drug Metab Dispos; 2006 Nov; 34(11):1893-902. PubMed ID: 16914511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450s in the development of target-based anticancer drugs.
    Purnapatre K; Khattar SK; Saini KS
    Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complexities inherent in attempts to decrease drug clearance by blocking sites of CYP-mediated metabolism.
    Fisher MB; Henne KR; Boer J
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):101-9. PubMed ID: 16445122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Metabolism in the Liver.
    Almazroo OA; Miah MK; Venkataramanan R
    Clin Liver Dis; 2017 Feb; 21(1):1-20. PubMed ID: 27842765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The P450 enzyme system: a key to understanding the metabolism of drugs.
    Bakutis AR
    AANA J; 1983 Jun; 51(3):272-4. PubMed ID: 6613503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications.
    Zhang YY; Yang L
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):621-9. PubMed ID: 19473111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.